Swine influenza is a persistent and costly respiratory disease that disrupts U.S. Pork production, costing producers hundreds of millions of dollars each year and threatening the affordability and…

Active Project Grant Awarded

Award ID
20263941046993
Recipient
Awarding agency
Obligated
$650,000

Award facts

Completion date 10% complete
Place of performance
Ames, IA 50010, USA

Award details come from USAspending.gov.

About this award

The USDA National Institute of Food and Agriculture awarded Genvax Technologies Inc. a $650,000 Project Grant on September 9, 2026, under Assistance Listing 10.212, Small Business Innovation Research (SBIR) Program / Small Business Technology Transfer (STTR) Program. The award funds an integrated, rapid-response vaccine system that connects diagnostic laboratories directly to veterinarians and digital manufacturing facilities to address swine influenza. Veterinarians use a secure online portal and artificial intelligence forecasting tools to track local virus strains in real time and order custom-matched RNA nanoparticle vaccines, which are manufactured and safety-tested in as short as four weeks. The source describes the project as replacing slow production methods with a traceable digital platform intended to protect animal welfare, stabilize farm incomes, and reduce animal-to-human disease transmission risk. The obligated amount is $650,000. The period of performance runs from September 9, 2026 to the ultimate completion date of September 14, 2028, and work is performed in Ames, Iowa 50010. The SBIR/STTR program supports small businesses in converting scientific discoveries into commercial products or services with commercial or societal potential, and the STTR component requires formal cooperative research and development with nonprofit research institutions. Grant records must be retained for at least three years and are subject to USDA Office of Inspector General audit.

Description

Swine influenza is a persistent and costly respiratory disease that disrupts U.S. Pork production, costing producers hundreds of millions of dollars each year and threatening the affordability and stability of the nation's food supply. Beyond farm-level economic impacts, the virus constantly mutates and can jump between pigs and humans, as seen during the 2009 H1N1 pandemic, making unmanaged outbreaks a serious public health and biosecurity concern. Traditional commercial vaccines often fail to keep up with newly emerging strains because they take too long to update and manufacture, leaving herds vulnerable to shifting viral variants.to solve this challenge, this project creates an integrated, rapid-response vaccine system that connects diagnostic laboratories directly to veterinarians and digital manufacturing facilities. Using a secure online portal and artificial intelligence forecasting tools, veterinarians can track local virus strains in real time and order custom-matched RNA nanoparticle vaccines that are manufactured and safety-tested in as short as four weeks. By replacing outdated, slow production methods with an agile and fully traceable digital platform, this work will protect animal welfare, stabilize farm incomes, lower food production costs, and reduce the risk of animal-to-human disease transmission.

Quick answers

Who received award 20263941046993?

20263941046993 was awarded to Genvax Technologies Inc. by Institute of Food Production and Sustainability (National Institute of Food and Agriculture) on September 9, 2026.

How much is award 20263941046993 worth?

$650,000 has been obligated on 20263941046993.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award